MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報，我們不為任何個人用途提供產(chǎn)品和服務(wù)。

GW9662

CAS No. : 22978-25-2

產(chǎn)品活性：GW9662 is a potent and selective PPARγ antagonist with an IC₅₀ of 3.3 nM, showing 10 and 1000-fold selectivity over PPARα and PPARδ, respectively.

研究領(lǐng)域：Cell Cycle/DNA Damage  |  Vitamin D Related/Nuclear Receptor

作用靶點：PPAR

In Vitro: GW9662 inhibits radioligand binding to PPARγ, PPARα, and PPARδ with pIC₅₀s of 8.48±0.27 (IC₅₀=3.3 nM; n=10), 7.49±0.17 (IC₅₀=32 nM; n=9), and 5.69±0.17 (IC₅₀=2000 nM; n=3), respectively. GW9662 has nanomolar IC₅₀ versus PPARγ and is 10- and 600-fold less potent in binding experiments using PPARα and PPARδ, respectively. In cell-based reporter assays, GW9662 is a potent and selective antagonist of full-length PPARγ. Co-treatment with both 50 μM BRL 49653 and 10 μM GW9662 results in statistically lower viable cell numbers after 7 days when compared to treatment with either 50 μM BRL 49653 (P=0.001) or 10 μM GW9662 (P=0.01) alone.

In Vivo: Bone marrow (BM) nucleated cell counts in both BADGE- and GW9662(1 mg/kg, i.p.)-treated mice are significantly higher than counts in the aplastic anemia (AA) group. GW9662 (1 mg/kg, i.p.) largely attenuates the renoprotective effects of Lipopolysaccharide (LPS) in the rat.

相關(guān)產(chǎn)品：Bioactive Compound Library Plus  |  Cell Cycle/DNA Damage Compound Library  |  Anti-Cancer Compound Library  |  Anti-Aging Compound Library  |  Anti-Obesity Compound Library  |  Transcription Factor-Targeted Library  |  Lipid Metabolism Compound Library   |  Human Metabolite Library  |  Nuclear Receptor Compound Library  |  LY518674  |  Bocidelpar  |  Retinoic acid  |  5-Aminosalicylic Acid-d₃ (hydrochloride)  |  Naveglitazar  |  Ertiprotafib  |  ATRA-biotin  |  Convallatoxin  |  MHY908  |  Ciprofibrate  |  MK-886  |  Bezafibrate-d₄  |  Mifobate  |  10-Nitrolinoleic acid  |  Magnolol  |  PPAR agonist 1  |  PTGR2-IN-1  |  GW1929 hydrochloride  |  Astaxanthin  |  H-?Trp-?Glu-?OH  |  Fmoc-leucine  |  PPARγ agonist 2  |  GSK0660  |  Pparδ agonist 1  |  MA-0204  |  Saroglitazar  |  Edaglitazone  |  Elafibranor  |  Mavodelpar

熱門產(chǎn)品線：重組蛋白  |  化合物庫  |  天然產(chǎn)物  |  熒光染料  |  PROTAC  |  同位素標(biāo)記物  |  寡核苷酸  |  抗體  |  點擊化學(xué)

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

品牌介紹:
•   MCE (MedChemExpress) 擁有200 多種全球僅有化合物庫，我們致力于為全球科研客戶提供前沿的高品質(zhì)小分子活性化合物；
•   50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領(lǐng)；
•   產(chǎn)品種類涵蓋各種重組蛋白，多肽，常用試劑盒 ，更有 PROTAC、ADC 等特色產(chǎn)品，廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項目；
•   提供虛擬篩選，離子通道篩選，代謝組學(xué)分析檢測分析，藥物篩選等專業(yè)技術(shù)服務(wù)；
•   設(shè)有專業(yè)的實驗中心和嚴(yán)格的質(zhì)控、驗證體系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質(zhì)檢報告，確保產(chǎn)品的高純度、高品質(zhì)；
•   產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證；
•   Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果；
•   專業(yè)團(tuán)隊跟蹤最新的制藥及生命科學(xué)研究進(jìn)展，為您提供全球新的活性化合物；
•   與世界各大制藥公司及著名科研機(jī)構(gòu)建立了長期的合作。